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Abstract
Organizing pneumonia can be idiopathic or caused by multiple etiologies, including viral or bacterial pneumonia, drugs,
and autoimmune disorders. It can rarely lead to cyst formation and pneumothorax with the exact mechanism remaining
unclear. This case presents a previously healthy 50-yearold male who contracted COVID-19 with subsequent development of organizing pneumonia and pneumothorax. Patients

presenting with hypoxic respiratory failure due to COVID19 should be screened for organizing pneumonia upon discharge. This case also illustrates the importance of following such patients radiologically to monitor interstitial lung disease and consider pneumothorax for patients re-presenting
with acute symptoms.

Introduction

lactate dehyrodgenase (LDH), and C-reactive protein
(CRP) were slightly elevated (381.2 ng/mL, 315 U/L,
and 4.486 mg/dL, respectively). The patient was recommended home isolation and discharged on antibiotics, a cough suppressant, and a short-acting inhaler.

Organizing pneumonia can be idiopathic or caused by
multiple etiologies, including viral or bacterial pneumonia, drugs, and autoimmune disorders.[1] It can
rarely lead to cyst formation and pneumothorax (PTX).
The exact mechanism is unclear. However, a possible
explanation is check valve mechanism.[2] We report a
case of COVID-19 pneumonia that was diagnosed with
organizing pneumonia radiologically. The patient presented later with cyst formation and PTX.

Case Description
A 50-year-old man with a medical history of mixed
hyperlipidemia and allergic rhinitis presented to the
emergency department for complaints of fever and
non-productive cough for 3 days. The patient was a
lifelong non-smoker with a body mass index (BMI) of
28.2 and no known exposure to animals or toxic fumes.
His temperature was 38.4 °C and oxygen saturation
(SpO2) was 98% on room air. Remaining vitals and
physical exam were unremarkable. Upon nasopharyngeal swab, the patient tested positive for COVID-19.
The patient’s chest X-ray (CXR) showed subtle patchy
opacities at both lung bases suspected to be developing pneumonia (Figure 1). The patient’s white blood
cell count was normal (4,500 per mm3 ), and ferritin,
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The patient returned to the emergency department four
days later due to worsening fever, cough, and new
onset dyspnea. His blood pressure (BP) was 151/81
mmHg, heart rate (HR) 100 beats/minute, respiratory
rate (RR) 28 breaths/minute, temperature 39.4 °C, and
SpO2 86% on room air. Auscultation revealed bilateral
wheezing, and CXR showed worsened patchy airspace
opacities throughout bilateral lungs consistent with a
diagnosis of COVID-19 pneumonia (Figure 2). Laboratory results showed elevated CRP 22.8, ferritin 1,477
nm/mL, LDH 526 U/L, and D-dimer 0.96 mcg/mL.
The patient was admitted to the hospital and placed on
supplemental oxygen with improvement of his SpO2 to
96%. He was also started on steroids, antibiotics, and
subcutaneous heparin prophylactically. Consent was
obtained for emergency use of antiviral therapy and
administration of convalescent plasma infusion. The
patient’s progressive decline in SpO2 prompted transfer to the intensive care unit and placement on heated
high flow nasal cannula. Over the next two days, he
required flows as high as 50 L/min with SpO2 fluctuating (82–98%). Inflammatory markers except D-
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Figure 1. Patient’s chest X-ray from initial emergency department
visit, when he was first diagnosed with COVID-19 and showed subtle
bilateral peripheral patchy opacities at both lung bases.

Figure 2. Patient’s chest X-ray from hospital day 0 of the first admission, which showed bilateral peripheral patchy opacities consistent
with COVID-19 pneumonia. This was 4 days after initial diagnosis.

dimer improved on day 6 (CRP 7.5 mg/dL, ferritin 786
nm/mL, LDH 443 U/L, and D-dimer 4.45 mcg/mL).
The patient’s oxygen requirements steadily decreased
over subsequent days, and the patient was transferred
to the medical ward. Computed tomography (CT) of
the chest on day 9 revealed persistent patchy mixed interstitial airspace opacities diffusely, with overall pattern consistent with organizing pneumonia (Figure 3).
No discrete effusion or PTX was noted. On day 11, the
patient was discharged home.

Discussion

The patient returned to emergency department on day
22 with sudden right-sided chest pain. Vital signs
were temperature 36.8 °C, HR 89 beats/minute, RR
15 breaths/minute, BP 181/82 mmHg, SpO2 99% on
room air. Chest CT revealed a small right anterior PTX
and bilateral multifocal ground glass interstitial opacities with no evidence of pulmonary embolism (Figure
4). Laboratory results showed persistently elevated ferritin, LDH, and D-dimer (523.9 ng/mL, 266 U/L, and
1.21 mcg/mL, respectively). He was placed on 15 L
oxygen by non-rebreather mask with 100% fraction of
inspired oxygen (FiO2). The patient improved clinically
and was subsequently discharged. Follow-up imaging 81 days from initial diagnosis showed resolution of
pneumothorax (Figure 5).

Our patient was initially treated for COVID-19 pneumonia and later discharged on a three-week steroid
taper based on a radiological diagnosis of organizing
pneumonia. We diagnosed this entity in the context
of COVID-19 and managed it with short courses of
steroids with good outcomes. In the current case, the
initial chest CT showed bilateral lower lobe ground
glass opacities consistent with acute COVID-19 pneumonia. His repeat chest CT obtained during readmission, in addition to PTX, also showed that the ground
glass opacities seen on chest CT originally had organized into a patchy bilateral curvilinear consolidation
pattern sparing the sub-pleural area, typical of organizing pneumonia.[3] A sizeable cyst was also seen.[4] It
is important to note that the location of this cyst was
peripheral, making it easy to rupture, which would introduce air into pleural space. Another important consideration is check valve mechanism in the context of
organizing pneumonia. It is plausible that the location
of the organizing pneumonia–type injury causing a peripheral cyst and check valve mechanism compromised
the integrity of the pleura, leading to the formation of
PTX.[5]
A literature search revealed a scant number of case reports exhibiting organizing pneumonia complicated by
cyst formation and PTX.[4-6] It is hypothesized that
there is obstruction of the bronchioles due to granulation plugs, which increases alveolar pressure during
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Figure 3. Patient’s chest computed tomography from hospital day 0 of the first admission, which showed bilateral patchy curvilinear consolidation
pattern with subpleural sparing consistent with organizing pneumonia post-COVID-19 infection.

Figure 4. Patient’s chest computed tomography from hospital day 0 of the second admission; a right lower lobe cyst can be seen adjacent to the
pleura and area of fibrosis. Right pneumothorax is visible anteriorly. This was 22 days after initial diagnosis.
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Figure 5. Patient’s chest computed tomography showed resolved pneumothorax at post-hospital follow-up. Curvilinear patchy opacities in lower
lobes suggest resolving organizing pneumonia. This was 81 days after initial diagnosis.

exhalation, resulting in over-inflation, which leads to
the formation of a cyst. Due to check valve mechanism,
air continues to enter the area of injury, resulting in air
trapping and cyst formation. The cyst finally ruptures
into the pleural space, causing PTX.[7]

due to COVID-19 should be screened for organizing
pneumonia upon discharge. This case illustrates the
importance of following such patients radiologically
to monitor interstitial lung disease and consider PTX
for patients re-presenting with acute symptoms (Figure
6—Appendix).

Patients presenting with hypoxic respiratory failure
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Appendix: Clinical Course
Table 1. Patient’s progression of inflammatory markers.

Hospital day

C-reactive protein (mg/dL)

Ferritin (ng/mL)

Lactate dehydrogenase (U/L)

D-dimer (mcg/mL)

0
4
6
7
8
22

4.48
22.8
7.5
4.85
7.01
2.93

381
1,477
786
612
673
369

315
526
443
403
494
177

0.27
0.96
4.45
40.26
108.71
1.21

Figure 6. Radiological timeline of events from patient’s initial presentation to final discharge.
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